T0	Participants 37 62	Wegener's granulomatosis.
T1	Participants 91 193	patients with Wegener's granulomatosis have disease flares after conventional medications are tapered.
T2	Participants 412 458	in 180 patients with Wegener's granulomatosis.
T3	Participants 969 1139	Of the 174 patients who could be evaluated, 126 (72.4 percent) had a sustained remission, but only 86 (49.4 percent) remained in remission for the remainder of the trial.
T4	Participants 2125 2192	maintenance of remission in patients with Wegener's granulomatosis.